Alx Oncology Holdings (ALXO) EV to EBITDA (2020 - 2026)
Powered by 
Analysis
Alx Oncology Holdings (ALXO) EV to EBITDA (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Alx Oncology Holdings | 273.31 Mn | 273.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.20 |
| Mar 31, 2026 | -3.68 |
| Dec 31, 2025 | -0.72 |
| Sep 30, 2025 | -1.66 |
| Jun 30, 2025 | 2.15 |
| Mar 31, 2025 | 2.03 |
| Dec 31, 2024 | 1.28 |
| Sep 30, 2024 | 1.61 |
| Jun 30, 2024 | -3.84 |
| Mar 31, 2024 | -10.68 |
| Dec 31, 2023 | -11.68 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -2.58 |
| Mar 31, 2023 | 1.34 |
| Dec 31, 2022 | -6.03 |
| Sep 30, 2022 | -2.86 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -14.97 |
| Dec 31, 2021 | -17.86 |
| Sep 30, 2021 | -106.00 |